Study of Inactivated, Split-Virion Influenza Vaccine [2007-2008 formulation] and Standard Fluzone Vaccine in Adult and Elderly Subjects

Trial Profile

Study of Inactivated, Split-Virion Influenza Vaccine [2007-2008 formulation] and Standard Fluzone Vaccine in Adult and Elderly Subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2016

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 10 Oct 2013 Primary endpoint 'Seroconversion-rate' has been met according to results published in Vaccine.
    • 10 Oct 2013 Primary endpoint 'Geometric-mean-antibody-titre' has been met according to results published in Vaccine.
    • 10 Oct 2013 Results published in Vaccine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top